1Brown TR. Handbook of Institutional Pharmacy Practice [ M ]. 4th. Bethesda: american society of health-system pharmacists publication production Center, :2006.
2Rubenfeld GD,Caldwell E,Peabody E,et al Incidence and outcomes of acute lung injury.N Engl J Med,2005,353(16):1685-1693.
3Phua J,Badia JR,Adhikari NK,et al.Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?:A Systematic Review.Am J Respir Crit Care Med,2009,179(3):220-227.
4Lu Y,Song Z,Zhou X,et al.A 12-month dinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive careunits.Intensive Care Med,2004,30(12):2197-2003.
5Wiedemann HP,Wheeler AP,Bernard GR,et al.National Heart,Lung,and Blood Institute Acute Respiratory Distress Syndrome (ARDS)Clinical Trials Network.Comparison of two fluid management strategies in acute lung injury.N Engl J Med,2006,354(24):2564-2575.
6Mangialardi RJ,Martin GS,Bernard GR,et al.Hypoproteinemia predicts acute respiratory distress syndrome development,weight gain,and death in patients with sepsis.Ibuprofen in Sepsis Study Group.Crit Care Med,2000,28(9):3137-3145.
7Martin GS,Mangialardi RJ,Wheeler AP,et al.Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury.Crit Care Med,2002,30(10):2175-2182.
8Martin GS,Moss M,Wheeler AP,et al.A randomized,controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury.Crit Care Med,2005,33(8):1681-1687.
9Peter JV,John P,Graham PL,et al.Corticosteroids in the prevention and treatment of acute respiratory distress syndrome(ARDS)in adults:meta-analysis.BMJ,2008,336(7651):1006-1009.
10Steinberg KP,Hudson LD,Goodman RB,et al.National Heart,Lung,and Blood Institute Acute Respiratory Distress Syndrome(ARDS)Clinical Trials Network.Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.N Engl J Med,2006,354(16):1671-1684.
